📚 Lecture Overview
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease characterized by multisystem involvement, significant morbidity, and mortality driven by an irreversible break in immunological tolerance. It predominantly affects women of childbearing age (9:1 female-to-male ratio) due to a complex interaction of genetic predisposition and environmental triggers. Mastery of its multisystem clinical manifestations, antibody profiles, and complication management is essential for clinical practice and exams.
🎯 Key Concepts & Definitions
- Systemic Lupus Erythematosus (SLE): A systemic autoimmune disease with multisystem involvement caused by immune responses against endogenous nuclear antigens.
- Antiphospholipid Syndrome (APS): A condition associated with SLE where abnormal antibodies make the blood "stickier," leading to blood clots in veins and arteries, plus pregnancy complications.
- Lipman-Sacks Verrucous Endocarditis: A specific, non-infectious form of endocarditis seen in SLE cardiovascular manifestations.
- Autoimmune Hemolytic Anemia: The most specific form of anemia in SLE, characterized by low hemoglobin, high reticulocyte count, high LDH, and a positive Coombs test.
- Lupus Nephritis (LN): Renal impairment affecting 25% of SLE patients, requiring early identification, biopsy classification, and immunosuppressive therapy.
📖 Main Content
Etiology and Pathogenesis
- The etiology involves genetic and environmental components, with female sex hormones strongly influencing pathogenesis.
- Genetic factors: Siblings of SLE patients are ~30 times more likely to develop the disease. Associated genes include HLA DR, PTPN22, STAT4, BANK1, SPP1, TNFAIP3, C2, C4, C1q, and DNA repair (TREX1).
- Environmental triggers: Ultraviolet light, demethylating drugs, infections, and hormonal factors (estrogen, prolactin, oral contraceptive pills).
- Pathogenesis process:
- Apoptotic cells release autoantigens.
- Dendritic cells present autoantigens to T cells, activating them.
- Activated T cells help B cells produce autoantibodies by secreting cytokines (IL-10, IL-23, CD40L, CTLA4).
Clinical Manifestations
- Dermatological: Butterfly or malar rash, discoid rash, photosensitivity, Raynaud's phenomenon, panniculus, urticaria, vasculitis, and livedo reticularis.
- Musculoskeletal: Mild, symmetrical, non-erosive arthritis presenting commonly as mild joint pain.
- Cardiovascular:
- Pericarditis is the most common (25% of cases), usually asymptomatic.
- Myocarditis (ranging from tachycardia to left heart failure).
- Lipman-Sacks verrucous endocarditis.
- Respiratory: Pleurisy (mild and recurrent), pneumonitis, alveolar interstitial hemorrhage, and pulmonary embolism.
- Renal: Affects 25% of patients; manifests as new-onset hypertension, edema, and laboratory changes. Requires classification via renal biopsy.
- Hematological:
- Anemia (Anemia of chronic illness is the most common; autoimmune hemolytic anemia is the most specific).
- Thrombocytopenia (low platelets with hypercellular bone marrow).
- Leukopenia (usually requires no extra treatment).
Antiphospholipid Syndrome (APS)
- Immune system produces abnormal antibodies making blood hypercoagulable.
- Arterial and venous complications: Deep vein thrombosis (DVT), stroke, TIA ("mini-stroke"), heart attacks, pulmonary embolism, and high blood pressure.
- Pregnancy complications:
- 3 or more unexplained early miscarriages (before 10 weeks).
- 1 or more late miscarriages (at or after 10 weeks).
- Premature birth (at or before 34 weeks) often linked to pre-eclampsia.
- Diagnostic criteria: Requires 1 clinical event (clot or pregnancy loss) plus 2 abnormal blood tests spaced at least 12 weeks apart.
- Antibodies tested: Anticardiolipin antibodies, lupus anticoagulant, and anti-beta-2 glycoprotein antibodies.
Investigations and Management
- Diagnostic Serology: ANA, anti-dsDNA, anti-Smith, anti-Ro, anti-La, lupus anticoagulant, beta-2 glycoprotein, and anticardiolipin.
- Follow-up Labs: ESR, CRP, C3, C4, anti-dsDNA, CBC, urea/creatinine, albumin/creatinine ratio, urinalysis, and renal biopsy.
- Treatment of Lupus Nephritis (LN):
- Multidisciplinary team approach.
- Controlled with corticosteroids and immunosuppressants/biologics (azathioprine, cyclosporin, cyclophosphamide, MMF, rituximab).
- Dialysis and transplantation have excellent long-term survival rates, with transplantation being the method of choice.
📊 Visual Learning
flowchart TD
A[Apoptosis] --> B[Autoantigens Released]
B --> C[Dendritic Cells]
C --> D[T Cell Activation]
D --> E[B Cell Activation]
E --> F[Autoantibody Production]
mindmap
root("SLE Manifestations")
"Dermatological"
"Malar Rash"
"Discoid Rash"
"Photosensitivity"
"Musculoskeletal"
"Non Erosive Arthritis"
"Cardiovascular"
"Pericarditis"
"Lipman Sacks Endocarditis"
"Renal"
"Lupus Nephritis"
"Hypertension"
graph LR
A[Abnormal Antibodies] --> B[Hypercoagulable Blood]
B --> C[Venous Clots DVT PE]
B --> D[Arterial Clots Stroke]
B --> E[Pregnancy Loss]
💡 Important Points to Remember
-
90% of SLE cases occur in women (9:1 F:M ratio), frequently during childbearing age (20–40 years).
- Genetics: Siblings of SLE patients have a 30 times higher risk of developing the disease.
- Hallmark Autoantibodies: Anti-dsDNA and Anti-Smith are key diagnostic markers.
- Arthritis profile: Lupus arthritis is classically non-erosive, differentiating it from rheumatoid arthritis.
- Most specific anemia: Autoimmune hemolytic anemia (positive Coombs test, high reticulocytes, high LDH).
- Most common CV manifestation: Pericarditis (present in 25% of cases).
- APS diagnosis rule: Requires a 12-week gap between two positive antibody tests.
- Renal involvement: 25% of patients develop Lupus Nephritis; renal biopsy is mandatory to guide therapy.
- Transplantation: Kidney transplantation is the method of choice for end-stage lupus nephritis with outcomes comparable to non-SLE patients.
- Common Confusion: Do not confuse the common anemia of chronic illness with the most specific anemia (autoimmune hemolytic anemia).
⚠️ Common Exam Questions
- MCQ Trick: Examiners often ask for the most specific anemia or cardiovascular manifestation. Students frequently guess "anemia of chronic illness" or "myocarditis" because they are common, missing that the correct answers for specific findings are autoimmune hemolytic anemia and Lipman-Sacks endocarditis.
- APS Case Scenarios: Expect clinical vignettes detailing pregnancy losses. Examiners will test the exact timeline requirement (e.g., miscarriages before vs. after 10 weeks) and the 12-week interval required between repeat antibody tests.
- Arthritis Distinction: Questions may contrast SLE arthritis with Rheumatoid Arthritis; remember SLE arthritis is non-erosive.
📦 Quick Review Checklist
I can explain the genetic and environmental etiology of SLE
I understand the pathogenesis involving dendritic cells, T cells, and B cells
I can list key dermatological and musculoskeletal features of SLE
I know the cardiovascular and hematological complications (including Lipman-Sacks and hemolytic anemia)
I understand the diagnostic criteria and antibody profile for Antiphospholipid Syndrome (APS)
I can differentiate between diagnostic serology and follow-up lab markers
I know how Lupus Nephritis is classified, monitored, and treated